/MKEA.PA
MKEA.PA Stock - Mauna Kea Technologies S.A.
Healthcare|Medical - DevicesPAR
$0.62+0.32%
+$0.00 (+0.32%) • Aug 7
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.56
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.62
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.68
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MKEA.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.62 – $0.63
TARGET (TP)$0.72
STOP LOSS$0.57
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.44
52W High$0.92
52W Low$0.40
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $7.48M | $7.70M | $6.53M | $7.43M | $6.76M |
| Gross Profit | $5.47M | $5.71M | $4.38M | $5.17M | $4.64M |
| Gross Margin | 73.2% | 74.2% | 67.1% | 69.6% | 68.7% |
| Operating Income | $-8,985,000 | $-11,371,000 | $-11,959,000 | $-13,028,000 | $-11,998,000 |
| Net Income | $-11,176,000 | $-14,320,000 | $-12,840,000 | $-15,375,000 | $-12,785,000 |
| Net Margin | -149.4% | -186.0% | -196.8% | -206.9% | -189.1% |
| EPS | $-0.21 | $-0.32 | $-0.36 | $-0.52 | $-0.47 |
Company Overview
Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MKEA.PABeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$N/A
EPS Surprise History
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2023 | Jul 20, 2023 | — | — | — | — |
Q2 2023 | Apr 20, 2023 | — | — | — | — |
Q4 2022 | Oct 27, 2022 | — | — | — | — |
Q3 2022 | Jul 21, 2022 | — | — | — | — |
Q2 2022 | Apr 21, 2022 | — | — | — | — |
Q1 2022 | Jan 20, 2022 | — | — | — | — |
Q4 2021 | Oct 28, 2021 | — | — | — | — |
Q3 2021 | Jul 22, 2021 | — | — | — | — |
Q1 2021 | Jan 21, 2021 | — | — | — | — |
Q4 2020 | Oct 19, 2020 | — | — | — | — |
Q3 2020 | Jul 20, 2020 | — | — | — | — |
Q2 2020 | Apr 28, 2020 | — | — | — | — |
Q1 2020 | Jan 29, 2020 | — | — | — | — |
Q4 2019 | Oct 17, 2019 | — | — | — | — |
Q1 2019 | Mar 20, 2019 | — | — | — | — |
Q4 2018 | Oct 18, 2018 | — | — | — | — |
Q3 2018 | Jul 25, 2018 | — | — | — | — |
Q2 2018 | Apr 25, 2018 | — | — | — | — |
Q4 2017 | Oct 19, 2017 | — | — | — | — |
Q3 2017 | Jul 26, 2017 | — | — | — | — |
Latest News
Loading news...
Frequently Asked Questions about MKEA.PA
What is MKEA.PA's current stock price?
Mauna Kea Technologies S.A. (MKEA.PA) is currently trading at $0.62 per share. The stock has moved +0.32% today.
What is the analyst price target for MKEA.PA?
No analyst price targets are currently available for this stock.
What sector is Mauna Kea Technologies S.A. in?
Mauna Kea Technologies S.A. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the PAR exchange.
What is MKEA.PA's market cap?
Mauna Kea Technologies S.A. has a market capitalization of $0.03 billion, making it a small-cap company.
Does MKEA.PA pay dividends?
No, Mauna Kea Technologies S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALCAR.PA
Carmat S.A.
$0.10
Mkt Cap: $0.0B
ALPHE.PA
Pherecydes Pharma S.A.
$2.00
Mkt Cap: $0.0B
ALTER.PA
Theradiag S.A.
$1.26
Mkt Cap: $0.0B
ALVET.PA
TheraVet S.A.
$0.08
Mkt Cap: $0.0B
APM.PA
Aptorum Group Limited
$3.21
Mkt Cap: $0.0B
COX.PA
Nicox S.A.
$0.58
Mkt Cap: $0.0B
FALG.PA
Fermentalg S.A.
$0.56
Mkt Cap: $0.0B
MLAHC.PA
Health S.A.
$0.60
Mkt Cap: $0.0B
MLBON.PA
bonyf N.V.
$6.30
Mkt Cap: $0.0B
MLMIB.PA
Metrics in Balance N.V.
$0.03
Mkt Cap: $0.0B
Explore stocks similar to MKEA.PA for comparison